--- title: "Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit" type: "News" locale: "en" url: "https://longbridge.com/en/news/290102632.md" description: "Lunai Bioworks secured its first revenue-generating multi-year U.S. defense collaboration with BioSymetrics for AI-enabled chemical threat assessment and formed the Pathfinder Consortium with several universities. Additionally, the company filed a lawsuit alleging naked short selling, seeking expedited discovery to identify parties responsible for 29.6 million failing-to-deliver shares." datetime: "2026-06-17T20:33:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290102632.md) - [en](https://longbridge.com/en/news/290102632.md) - [zh-HK](https://longbridge.com/zh-HK/news/290102632.md) generator: "portal-rs" --- # Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit **Lunai Bioworks announced its first revenue-generating multi-year U.S. defense collaboration and has initiated expedited discovery in litigation over alleged naked short selling.** **Key Highlights:** - Secured first revenue-generating, multi-year defense collaboration with BioSymetrics for AI-enabled chemical threat assessment. - Formed the Pathfinder Consortium with Harvard, Brigham and Women’s, Utah, Purdue and Colorado to strengthen scientific and national-security ties. - Augusta platform aligns with 2027 Defense Authorization priorities for AI-enabled high-throughput chemical neurotoxic threat identification. - Advancing precision neurology programs and collaborations, including BrainStorm Therapeutics and NIH-supported STTR grant awarded to BioSymetrics ($1.85M). - Filed suit alleging naked short selling with expedited discovery after evidence of 29.6M failing-to-deliver shares and extreme intraday volume; discovery underway to identify responsible parties. Original SEC Filing: Lunai Bioworks Inc. \[ LNAI \] - 8-K - Jun. 17, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md) - [BCLI.US](https://longbridge.com/en/quote/BCLI.US.md) - [RENB.US](https://longbridge.com/en/quote/RENB.US.md) ## Related News & Research - [Is the AI bubble bursting?](https://longbridge.com/en/news/298981516.md) - [A legal AI startup has a plan to take on Lexis Nexis and Westlaw](https://longbridge.com/en/news/298892675.md) - [How Meta tried, and failed, to grab its employees' data for AI](https://longbridge.com/en/news/298706095.md) - [3 forgotten AI stocks that should rebound from their corrections](https://longbridge.com/en/news/298812719.md) - [Thales sets out four-pillar “Trustworthy AI” ESG framework on validity, security, transparency, accountability](https://longbridge.com/en/news/298372315.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**